about
Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current DogmaThe intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines.Poly-functional and long-lasting anticancer immune response elicited by a safe attenuated Pseudomonas aeruginosa vector for antigens delivery.Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy.Cell-death-associated molecular patterns as determinants of cancer immunogenicity.CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy.Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy.Photochemotherapy induces the apoptosis of monocytes without impairing their function.Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.Extracorporeal photochemotherapy induces arginase 1 in patients with graft versus host disease.Harnessing γδ T cells in anticancer immunotherapyCryopreservation of mononuclear cells before extracorporeal photochemotherapy does not impair their anti-proliferative capabilitiesLa photochimiothérapie extracorporelle ou l’immunothérapie par cellules modifiées par photochimieImmunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graftPhotochemotherapy Induces a Faster Apoptosis of Alloreactive Activated T Cells Than of Nonalloreactive Resting T Cells in Graft Versus Host DiseaseArgumentaire pour une utilisation plus large de la photochimiothérapie extracorporelle chez l’enfantPhotopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of conceptIn vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis
P50
Q26798468-90FDD496-5CF1-42C3-8EE3-5B5AB6BCCD70Q31144277-D1F7E28E-E5D7-4789-9E63-C486DF89531FQ36293343-E7AFA4B2-410D-472D-BA47-C47EE8F69702Q37379394-E4A7191D-BC8C-4C75-AFD4-BEBE75AEFCB6Q37379398-2B8A15D6-502E-4B5F-AE47-D8EF872E31A1Q37502444-AB29E2F3-0E0E-47CF-AC6A-E601C7931927Q37939525-C1CF2A08-89FB-4F89-8177-A9B8C818EF53Q38080191-D8FBC766-BCED-4580-A6D6-68B55116E0EEQ39049614-13202418-C041-4A81-B717-3FE1581F8A7DQ39170477-D623D484-9DE6-4D61-90C7-12AFB5B46453Q41827468-A8CD7D5E-4467-4CBF-BA2E-ECD837ED0DAEQ42161868-56E916C9-9054-4491-8BAC-AAEF9EA7D3C8Q42182888-5C475C9A-EC1E-4E14-A3E1-4BEA76E72825Q43175108-2CD7C961-BF5F-4A69-ACC9-AC2F274CF3B5Q54403875-CEC27205-2190-4457-B9FA-C50890DEADA1Q59387577-913DD54A-5111-4100-9758-3D9FF6437D52Q59387578-D14A82AB-ECAD-4FAA-9BD2-FD3093FA982FQ59387580-974171D3-F3E9-4AFB-A80C-3C0631FD3309Q59387582-0C989276-F3BE-4D32-880F-AEBD431BC13AQ59387583-D23CFE5E-E1A3-49D9-838E-1A0A67506283Q59387584-E0E24B21-8068-4827-8D87-3CA29E6CC051Q90166210-ACA85BF7-ED3D-41DC-B794-AE94DCD505FFQ92297445-2E6B505D-CDBE-49A4-8BE6-76DFDA4E713D
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Dalil Hannani
@ast
Dalil Hannani
@en
Dalil Hannani
@es
Dalil Hannani
@nl
Dalil Hannani
@sl
type
label
Dalil Hannani
@ast
Dalil Hannani
@en
Dalil Hannani
@es
Dalil Hannani
@nl
Dalil Hannani
@sl
prefLabel
Dalil Hannani
@ast
Dalil Hannani
@en
Dalil Hannani
@es
Dalil Hannani
@nl
Dalil Hannani
@sl
P214
P106
P1153
35363868000
P21
P214
P31
P496
0000-0001-5097-1401
P7859
viaf-201234515